

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * complement activation (GO:0006956) | 9.76266211 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 9.01522072 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.80120753 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.80120753 |
| 5 | negative regulation of glucose import (GO:0046325) | 7.69180033 |
| 6 | B cell receptor signaling pathway (GO:0050853) | 7.47250905 |
| 7 | signal peptide processing (GO:0006465) | 6.93859275 |
| 8 | negative regulation of B cell proliferation (GO:0030889) | 6.36171610 |
| 9 | positive regulation of respiratory burst (GO:0060267) | 6.35314706 |
| 10 | * Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 6.33859053 |
| 11 | * immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 6.33859053 |
| 12 | * Fc-gamma receptor signaling pathway (GO:0038094) | 6.33859053 |
| 13 | * Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 6.25123213 |
| 14 | * protein activation cascade (GO:0072376) | 6.24429797 |
| 15 | negative regulation of glucose transport (GO:0010829) | 6.23608790 |
| 16 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 5.93602851 |
| 17 | * humoral immune response (GO:0006959) | 5.87490085 |
| 18 | regulation of B cell proliferation (GO:0030888) | 5.55514650 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.54754378 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.47108884 |
| 21 | positive regulation of B cell differentiation (GO:0045579) | 5.41011467 |
| 22 | regulation of B cell differentiation (GO:0045577) | 5.30199824 |
| 23 | retina homeostasis (GO:0001895) | 5.23346376 |
| 24 | mesoderm development (GO:0007498) | 5.15942828 |
| 25 | cellular response to zinc ion (GO:0071294) | 4.77473908 |
| 26 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 4.68447600 |
| 27 | glomerular filtration (GO:0003094) | 4.67897489 |
| 28 | N-acetylneuraminate metabolic process (GO:0006054) | 4.56969478 |
| 29 | mesenchyme development (GO:0060485) | 4.55858176 |
| 30 | mature B cell differentiation (GO:0002335) | 4.55265258 |
| 31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.53156379 |
| 32 | B cell proliferation (GO:0042100) | 4.51495892 |
| 33 | regulation of respiratory burst (GO:0060263) | 4.39939688 |
| 34 | positive regulation of immunoglobulin production (GO:0002639) | 4.34745927 |
| 35 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.34070809 |
| 36 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.28069066 |
| 37 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.23512988 |
| 38 | renal filtration (GO:0097205) | 4.17981654 |
| 39 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.13108074 |
| 40 | positive regulation of Rap GTPase activity (GO:0032854) | 4.09632966 |
| 41 | antimicrobial humoral response (GO:0019730) | 4.09458240 |
| 42 | L-fucose metabolic process (GO:0042354) | 4.08688721 |
| 43 | L-fucose catabolic process (GO:0042355) | 4.08688721 |
| 44 | fucose catabolic process (GO:0019317) | 4.08688721 |
| 45 | respiratory burst (GO:0045730) | 4.01979741 |
| 46 | gonadal mesoderm development (GO:0007506) | 37.3605667 |
| 47 | antibacterial humoral response (GO:0019731) | 3.95224374 |
| 48 | mature B cell differentiation involved in immune response (GO:0002313) | 3.94839881 |
| 49 | regulation of B cell activation (GO:0050864) | 3.88922862 |
| 50 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.76081898 |
| 51 | apoptotic cell clearance (GO:0043277) | 3.75506460 |
| 52 | regulation of B cell apoptotic process (GO:0002902) | 3.73262366 |
| 53 | B cell homeostasis (GO:0001782) | 3.73188047 |
| 54 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.70481697 |
| 55 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.69118309 |
| 56 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.63586184 |
| 57 | exocrine pancreas development (GO:0031017) | 3.61132493 |
| 58 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.52871036 |
| 59 | cytidine catabolic process (GO:0006216) | 3.42819314 |
| 60 | cytidine deamination (GO:0009972) | 3.42819314 |
| 61 | cytidine metabolic process (GO:0046087) | 3.42819314 |
| 62 | regulation of Rap GTPase activity (GO:0032317) | 3.41482100 |
| 63 | * immune response-activating signal transduction (GO:0002757) | 3.39815893 |
| 64 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.38232811 |
| 65 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.37920076 |
| 66 | regulation of cellular extravasation (GO:0002691) | 3.37601797 |
| 67 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.34256636 |
| 68 | natural killer cell mediated immunity (GO:0002228) | 3.33886175 |
| 69 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.33886175 |
| 70 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.32097439 |
| 71 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.28437222 |
| 72 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 3.26632191 |
| 73 | cellular response to antibiotic (GO:0071236) | 3.25710515 |
| 74 | positive regulation of nuclease activity (GO:0032075) | 3.25365552 |
| 75 | B cell activation (GO:0042113) | 3.25313217 |
| 76 | peptidyl-asparagine modification (GO:0018196) | 3.24880343 |
| 77 | positive regulation of B cell proliferation (GO:0030890) | 3.24136489 |
| 78 | regulation of immunoglobulin production (GO:0002637) | 3.23651308 |
| 79 | negative regulation of B cell activation (GO:0050869) | 3.23570233 |
| 80 | cellular response to unfolded protein (GO:0034620) | 3.22771813 |
| 81 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.21831255 |
| 82 | positive regulation of antigen processing and presentation (GO:0002579) | 3.21638253 |
| 83 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.20085849 |
| 84 | NADH metabolic process (GO:0006734) | 3.18034849 |
| 85 | regulation of nuclease activity (GO:0032069) | 3.17120003 |
| 86 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.15404406 |
| 87 | cellular response to type I interferon (GO:0071357) | 3.12831037 |
| 88 | type I interferon signaling pathway (GO:0060337) | 3.12831037 |
| 89 | regulation of antigen processing and presentation (GO:0002577) | 3.10977077 |
| 90 | response to type I interferon (GO:0034340) | 3.10294583 |
| 91 | defense response to Gram-negative bacterium (GO:0050829) | 3.09438675 |
| 92 | positive regulation of B cell activation (GO:0050871) | 3.09368212 |
| 93 | defense response to protozoan (GO:0042832) | 3.07808635 |
| 94 | * activation of immune response (GO:0002253) | 3.06761922 |
| 95 | negative T cell selection (GO:0043383) | 3.06243809 |
| 96 | response to endoplasmic reticulum stress (GO:0034976) | 3.05506865 |
| 97 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.05426595 |
| 98 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.05299303 |
| 99 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.05299303 |
| 100 | negative thymic T cell selection (GO:0045060) | 3.04795682 |
| 101 | immunoglobulin mediated immune response (GO:0016064) | 3.04769685 |
| 102 | phenylpropanoid metabolic process (GO:0009698) | 3.04672206 |
| 103 | Golgi transport vesicle coating (GO:0048200) | 3.03806405 |
| 104 | COPI coating of Golgi vesicle (GO:0048205) | 3.03806405 |
| 105 | positive thymic T cell selection (GO:0045059) | 3.03480523 |
| 106 | I-kappaB phosphorylation (GO:0007252) | 3.03362051 |
| 107 | cellular response to topologically incorrect protein (GO:0035967) | 3.01288352 |
| 108 | regulation of gamma-delta T cell activation (GO:0046643) | 3.00935582 |
| 109 | * immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 3.00681305 |
| 110 | protein N-linked glycosylation (GO:0006487) | 3.00025199 |
| 111 | negative regulation of B cell apoptotic process (GO:0002903) | 2.96454404 |
| 112 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.95003747 |
| 113 | lymphocyte homeostasis (GO:0002260) | 2.93557677 |
| 114 | ER-nucleus signaling pathway (GO:0006984) | 2.92798958 |
| 115 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.90930277 |
| 116 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.90470276 |
| 117 | positive regulation of production of molecular mediator of immune response (GO:0002702) | 2.89416969 |
| 118 | nucleosome assembly (GO:0006334) | 2.85309952 |
| 119 | NIK/NF-kappaB signaling (GO:0038061) | 2.84142764 |
| 120 | germinal center formation (GO:0002467) | 2.81036256 |
| 121 | detection of bacterium (GO:0016045) | 2.74801290 |
| 122 | B cell mediated immunity (GO:0019724) | 2.72248273 |
| 123 | T cell migration (GO:0072678) | 2.71414491 |
| 124 | sex differentiation (GO:0007548) | 2.70061312 |
| 125 | positive regulation of pseudopodium assembly (GO:0031274) | 2.69151439 |
| 126 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.67252173 |
| 127 | thymic T cell selection (GO:0045061) | 2.66653542 |
| 128 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.65693719 |
| 129 | myeloid dendritic cell differentiation (GO:0043011) | 2.62727843 |
| 130 | dendritic cell chemotaxis (GO:0002407) | 2.59123864 |
| 131 | cellular response to interferon-gamma (GO:0071346) | 2.58737671 |
| 132 | detection of other organism (GO:0098543) | 2.56289829 |
| 133 | angiotensin maturation (GO:0002003) | 2.56244715 |
| 134 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.54374618 |
| 135 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.50446422 |
| 136 | T cell costimulation (GO:0031295) | 2.47629684 |
| 137 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.47568969 |
| 138 | keratinization (GO:0031424) | 2.47178171 |
| 139 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.45297913 |
| 140 | lymphocyte costimulation (GO:0031294) | 2.43714838 |
| 141 | response to interferon-gamma (GO:0034341) | 2.43656839 |
| 142 | myeloid dendritic cell activation (GO:0001773) | 2.42332189 |
| 143 | regulation of pseudopodium assembly (GO:0031272) | 2.38032841 |
| 144 | negative regulation of viral release from host cell (GO:1902187) | 2.36115485 |
| 145 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.32445578 |
| 146 | midgut development (GO:0007494) | 2.30711247 |
| 147 | regulation of viral release from host cell (GO:1902186) | 2.30461166 |
| 148 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.29357065 |
| 149 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.28906304 |
| 150 | cytokine biosynthetic process (GO:0042089) | 2.26836830 |
| 151 | negative regulation of cell killing (GO:0031342) | 2.26708286 |
| 152 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.26708286 |
| 153 | response to nitric oxide (GO:0071731) | 2.25620658 |
| 154 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.24833404 |
| 155 | protein-DNA complex assembly (GO:0065004) | 2.23878290 |
| 156 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.23768189 |
| 157 | peptide catabolic process (GO:0043171) | 2.20649834 |
| 158 | T cell selection (GO:0045058) | 2.20031695 |
| 159 | protein-chromophore linkage (GO:0018298) | 2.16939878 |
| 160 | organ or tissue specific immune response (GO:0002251) | 2.15635776 |
| 161 | nucleosome organization (GO:0034728) | 2.15547926 |
| 162 | positive regulation of T cell migration (GO:2000406) | 2.15494240 |
| 163 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.12510086 |
| 164 | dendritic cell migration (GO:0036336) | 2.11686830 |
| 165 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.11343291 |
| 166 | lymphocyte migration (GO:0072676) | 2.10834308 |
| 167 | regulation of T cell migration (GO:2000404) | 2.10606832 |
| 168 | production of molecular mediator of immune response (GO:0002440) | 2.06427839 |
| 169 | positive regulation of lymphocyte migration (GO:2000403) | 2.06239210 |
| 170 | GDP-mannose metabolic process (GO:0019673) | 2.06186079 |
| 171 | * complement activation, classical pathway (GO:0006958) | 12.8816330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.40221815 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.41694797 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.06152674 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.61946019 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 4.39849931 |
| 6 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 4.05893133 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.84177850 |
| 8 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.54543620 |
| 9 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.45708218 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.44347191 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.00366491 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.92308621 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.89406109 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.86980959 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.68372947 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.65851512 |
| 17 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.50054938 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.49653149 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.40122585 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.38572896 |
| 21 | MYB_26560356_Chip-Seq_TH1_Human | 2.36174007 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.35622254 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.30417034 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.21696827 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.16606003 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.11147680 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.07641704 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 2.01278907 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.99840909 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.99408377 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93129203 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.92117436 |
| 33 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.89965064 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.89313471 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.85912134 |
| 36 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.83861872 |
| 37 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.82805804 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81276345 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.73636610 |
| 40 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.73080103 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.60430282 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.59143317 |
| 43 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.58831694 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58355677 |
| 45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.55695987 |
| 46 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.53880070 |
| 47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.53435552 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.53040101 |
| 49 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.50890418 |
| 50 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.49518184 |
| 51 | MAF_26560356_Chip-Seq_TH2_Human | 1.47520746 |
| 52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.46101342 |
| 53 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.42698009 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37307274 |
| 55 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37086510 |
| 56 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.35998848 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.35141820 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34929083 |
| 59 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32965452 |
| 60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30900559 |
| 61 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28410252 |
| 62 | GATA3_26560356_Chip-Seq_TH2_Human | 1.27705678 |
| 63 | SPI1_23127762_ChIP-Seq_K562_Human | 1.24377669 |
| 64 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.23556168 |
| 65 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20421682 |
| 66 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20067390 |
| 67 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.15786034 |
| 68 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.15401558 |
| 69 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15047936 |
| 70 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.13775146 |
| 71 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13202930 |
| 72 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.12456308 |
| 73 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11767900 |
| 74 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.11371616 |
| 75 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.08674739 |
| 76 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.08053100 |
| 77 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06584060 |
| 78 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.05200333 |
| 79 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04278341 |
| 80 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.04061008 |
| 81 | GATA1_22025678_ChIP-Seq_K562_Human | 1.02488359 |
| 82 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.01331544 |
| 83 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00346302 |
| 84 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00147029 |
| 85 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99922908 |
| 86 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.99634443 |
| 87 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99434713 |
| 88 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.99351913 |
| 89 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99064849 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98869073 |
| 91 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.98436426 |
| 92 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.98414759 |
| 93 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96602264 |
| 94 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96365532 |
| 95 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.96326255 |
| 96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96233227 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95933506 |
| 98 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.95636334 |
| 99 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.94497279 |
| 100 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.94154085 |
| 101 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93007349 |
| 102 | P300_27268052_Chip-Seq_Bcells_Human | 0.92794728 |
| 103 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.92764512 |
| 104 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92625731 |
| 105 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.91237368 |
| 106 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.91155572 |
| 107 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90724224 |
| 108 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.90456927 |
| 109 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.90282836 |
| 110 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.90026148 |
| 111 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89019444 |
| 112 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.88036131 |
| 113 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.87623770 |
| 114 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87187700 |
| 115 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.86973918 |
| 116 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85672373 |
| 117 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.85428797 |
| 118 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.84589823 |
| 119 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.84435864 |
| 120 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84153693 |
| 121 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.83865408 |
| 122 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81104539 |
| 123 | GATA3_26560356_Chip-Seq_TH1_Human | 0.80866862 |
| 124 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.80758028 |
| 125 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80509956 |
| 126 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79041397 |
| 127 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.77717901 |
| 128 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77208813 |
| 129 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.77106085 |
| 130 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.75742795 |
| 131 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75029408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 6.46670199 |
| 2 | MP0001800_abnormal_humoral_immune | 5.04255557 |
| 3 | MP0005387_immune_system_phenotype | 4.54219767 |
| 4 | MP0001790_abnormal_immune_system | 4.54219767 |
| 5 | MP0003303_peritoneal_inflammation | 4.22125487 |
| 6 | MP0002452_abnormal_antigen_presenting | 3.78670772 |
| 7 | MP0005671_abnormal_response_to | 3.69517968 |
| 8 | MP0002723_abnormal_immune_serum | 3.18882823 |
| 9 | MP0000685_abnormal_immune_system | 3.17656898 |
| 10 | MP0005000_abnormal_immune_tolerance | 3.07979934 |
| 11 | MP0002420_abnormal_adaptive_immunity | 3.06830051 |
| 12 | MP0001819_abnormal_immune_cell | 3.00060531 |
| 13 | MP0002398_abnormal_bone_marrow | 2.83458326 |
| 14 | MP0004264_abnormal_extraembryonic_tissu | 2.80225542 |
| 15 | MP0000716_abnormal_immune_system | 2.71193591 |
| 16 | MP0003724_increased_susceptibility_to | 2.68433068 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.59285652 |
| 18 | MP0000689_abnormal_spleen_morphology | 2.56794939 |
| 19 | MP0005025_abnormal_response_to | 2.44214121 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.29767123 |
| 21 | MP0001879_abnormal_lymphatic_vessel | 2.28320728 |
| 22 | MP0002429_abnormal_blood_cell | 2.24389366 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.23180213 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.12522260 |
| 25 | MP0002722_abnormal_immune_system | 2.04530505 |
| 26 | MP0003763_abnormal_thymus_physiology | 2.01568945 |
| 27 | MP0002419_abnormal_innate_immunity | 2.00909720 |
| 28 | MP0003436_decreased_susceptibility_to | 2.00694602 |
| 29 | MP0009785_altered_susceptibility_to | 1.99240096 |
| 30 | MP0001348_abnormal_lacrimal_gland | 1.89062467 |
| 31 | MP0008438_abnormal_cutaneous_collagen | 1.87762774 |
| 32 | MP0002796_impaired_skin_barrier | 1.86605112 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.84793548 |
| 34 | MP0005275_abnormal_skin_tensile | 1.77951001 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.76550674 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.74637643 |
| 37 | MP0002006_tumorigenesis | 1.72451062 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.60369722 |
| 39 | MP0001853_heart_inflammation | 1.57857698 |
| 40 | MP0006054_spinal_hemorrhage | 1.57734171 |
| 41 | MP0002405_respiratory_system_inflammati | 1.57271786 |
| 42 | MP0004947_skin_inflammation | 1.53472669 |
| 43 | MP0005166_decreased_susceptibility_to | 1.47788705 |
| 44 | MP0005310_abnormal_salivary_gland | 1.47554867 |
| 45 | MP0002933_joint_inflammation | 1.46467854 |
| 46 | MP0004510_myositis | 1.42152945 |
| 47 | MP0005360_urolithiasis | 1.35756146 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.35149405 |
| 49 | MP0003693_abnormal_embryo_hatching | 1.32823547 |
| 50 | MP0004782_abnormal_surfactant_physiolog | 1.32337813 |
| 51 | MP0001666_abnormal_nutrient_absorption | 1.22075942 |
| 52 | MP0002139_abnormal_hepatobiliary_system | 1.20473218 |
| 53 | MP0001873_stomach_inflammation | 1.20188601 |
| 54 | MP0002396_abnormal_hematopoietic_system | 1.20049266 |
| 55 | MP0003866_abnormal_defecation | 1.19592553 |
| 56 | MP0002019_abnormal_tumor_incidence | 1.19149137 |
| 57 | MP0000490_abnormal_crypts_of | 1.18777943 |
| 58 | MP0004043_abnormal_pH_regulation | 1.15322952 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.15110907 |
| 60 | MP0005381_digestive/alimentary_phenotyp | 1.12409810 |
| 61 | MP0005464_abnormal_platelet_physiology | 1.08834678 |
| 62 | MP0003806_abnormal_nucleotide_metabolis | 1.03820868 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.02639952 |
| 64 | MP0002136_abnormal_kidney_physiology | 1.01712129 |
| 65 | MP0003868_abnormal_feces_composition | 1.00276491 |
| 66 | MP0006082_CNS_inflammation | 0.97245165 |
| 67 | MP0004808_abnormal_hematopoietic_stem | 0.95206956 |
| 68 | MP0008469_abnormal_protein_level | 0.91040847 |
| 69 | MP0003075_altered_response_to | 0.90866213 |
| 70 | MP0003195_calcinosis | 0.86522950 |
| 71 | MP0001851_eye_inflammation | 0.85639202 |
| 72 | MP0008004_abnormal_stomach_pH | 0.84506276 |
| 73 | MP0003453_abnormal_keratinocyte_physiol | 0.84471476 |
| 74 | MP0005085_abnormal_gallbladder_physiolo | 0.83725401 |
| 75 | MP0005501_abnormal_skin_physiology | 0.82767331 |
| 76 | MP0000343_altered_response_to | 0.82472138 |
| 77 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81857011 |
| 78 | MP0001545_abnormal_hematopoietic_system | 0.81494109 |
| 79 | MP0005397_hematopoietic_system_phenotyp | 0.81494109 |
| 80 | MP0002168_other_aberrant_phenotype | 0.79753573 |
| 81 | MP0002693_abnormal_pancreas_physiology | 0.78579084 |
| 82 | MP0001216_abnormal_epidermal_layer | 0.78423399 |
| 83 | MP0002060_abnormal_skin_morphology | 0.77896962 |
| 84 | MP0001191_abnormal_skin_condition | 0.76938821 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 0.74951504 |
| 86 | MP0003448_altered_tumor_morphology | 0.74701155 |
| 87 | MP0001533_abnormal_skeleton_physiology | 0.73575630 |
| 88 | MP0005171_absent_coat_pigmentation | 0.72341732 |
| 89 | MP0004957_abnormal_blastocyst_morpholog | 0.72121639 |
| 90 | MP0005076_abnormal_cell_differentiation | 0.71845401 |
| 91 | MP0000003_abnormal_adipose_tissue | 0.71142414 |
| 92 | MP0004858_abnormal_nervous_system | 0.69612480 |
| 93 | MP0005165_increased_susceptibility_to | 0.69573459 |
| 94 | MP0003045_fibrosis | 0.69152343 |
| 95 | MP0001663_abnormal_digestive_system | 0.69090148 |
| 96 | MP0001664_abnormal_digestion | 0.67581492 |
| 97 | MP0010307_abnormal_tumor_latency | 0.67153414 |
| 98 | MP0000609_abnormal_liver_physiology | 0.66891791 |
| 99 | MP0008057_abnormal_DNA_replication | 0.66482679 |
| 100 | MP0003795_abnormal_bone_structure | 0.64335142 |
| 101 | MP0005503_abnormal_tendon_morphology | 0.63378456 |
| 102 | MP0003828_pulmonary_edema | 0.63090999 |
| 103 | MP0003943_abnormal_hepatobiliary_system | 0.63010571 |
| 104 | MP0003172_abnormal_lysosome_physiology | 0.61603320 |
| 105 | MP0005058_abnormal_lysosome_morphology | 0.61315651 |
| 106 | MP0005451_abnormal_body_composition | 0.61193472 |
| 107 | MP0003077_abnormal_cell_cycle | 0.60997031 |
| 108 | MP0010352_gastrointestinal_tract_polyps | 0.60430491 |
| 109 | MP0001919_abnormal_reproductive_system | 0.60246802 |
| 110 | MP0001944_abnormal_pancreas_morphology | 0.60204755 |
| 111 | MP0009764_decreased_sensitivity_to | 0.58324387 |
| 112 | MP0000858_altered_metastatic_potential | 0.58043850 |
| 113 | MP0005023_abnormal_wound_healing | 0.57922354 |
| 114 | MP0003191_abnormal_cellular_cholesterol | 0.56514096 |
| 115 | MP0000477_abnormal_intestine_morphology | 0.55921218 |
| 116 | MP0002083_premature_death | 0.55646376 |
| 117 | MP0002877_abnormal_melanocyte_morpholog | 0.54851797 |
| 118 | MP0009931_abnormal_skin_appearance | 0.51944087 |
| 119 | MP0005388_respiratory_system_phenotype | 0.48896396 |
| 120 | MP0002133_abnormal_respiratory_system | 0.48896396 |
| 121 | MP0009643_abnormal_urine_homeostasis | 0.48715126 |
| 122 | MP0000639_abnormal_adrenal_gland | 0.47421654 |
| 123 | MP0005621_abnormal_cell_physiology | 0.45759749 |
| 124 | MP0009840_abnormal_foam_cell | 0.45736357 |
| 125 | MP0000350_abnormal_cell_proliferation | 0.44895952 |
| 126 | MP0009763_increased_sensitivity_to | 0.43681486 |
| 127 | MP0003091_abnormal_cell_migration | 0.43600059 |
| 128 | MP0000733_abnormal_muscle_development | 0.43088634 |
| 129 | MP0002998_abnormal_bone_remodeling | 0.42213718 |
| 130 | MP0000313_abnormal_cell_death | 0.41559221 |
| 131 | MP0009278_abnormal_bone_marrow | 0.41317868 |
| 132 | MP0002909_abnormal_adrenal_gland | 0.39330218 |
| 133 | MP0008874_decreased_physiological_sensi | 0.37994433 |
| 134 | MP0003186_abnormal_redox_activity | 0.37143099 |
| 135 | MP0005174_abnormal_tail_pigmentation | 0.36625169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B lymphocytopenia (HP:0010976) | 7.60027582 |
| 2 | Abnormality of B cell number (HP:0010975) | 7.60027582 |
| 3 | Colitis (HP:0002583) | 7.54545522 |
| 4 | Recurrent sinusitis (HP:0011108) | 7.47277349 |
| 5 | Recurrent bronchitis (HP:0002837) | 7.34911730 |
| 6 | Cellulitis (HP:0100658) | 6.83179680 |
| 7 | Gastrointestinal stroma tumor (HP:0100723) | 6.56990316 |
| 8 | Papilloma (HP:0012740) | 5.99954181 |
| 9 | Verrucae (HP:0200043) | 5.99954181 |
| 10 | IgM deficiency (HP:0002850) | 5.81438775 |
| 11 | Inflammation of the large intestine (HP:0002037) | 5.81154872 |
| 12 | Gastrointestinal inflammation (HP:0004386) | 5.51457367 |
| 13 | Recurrent viral infections (HP:0004429) | 5.36130141 |
| 14 | Recurrent pneumonia (HP:0006532) | 5.25508991 |
| 15 | Meningitis (HP:0001287) | 5.12979706 |
| 16 | Chronic sinusitis (HP:0011109) | 5.00836721 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 4.69443704 |
| 18 | Chronic otitis media (HP:0000389) | 4.47488989 |
| 19 | Recurrent lower respiratory tract infections (HP:0002783) | 4.43899027 |
| 20 | Bronchitis (HP:0012387) | 4.37574389 |
| 21 | Emphysema (HP:0002097) | 4.30981607 |
| 22 | Osteomyelitis (HP:0002754) | 4.25036964 |
| 23 | Recurrent otitis media (HP:0000403) | 4.17785269 |
| 24 | Prostate neoplasm (HP:0100787) | 3.83654668 |
| 25 | Lymphopenia (HP:0001888) | 3.66575303 |
| 26 | Interstitial pulmonary disease (HP:0006530) | 3.64219623 |
| 27 | IgA deficiency (HP:0002720) | 3.60329748 |
| 28 | Malnutrition (HP:0004395) | 3.55049468 |
| 29 | Sepsis (HP:0100806) | 3.49195451 |
| 30 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.48611814 |
| 31 | Skin rash (HP:0000988) | 3.48021658 |
| 32 | Vasculitis (HP:0002633) | 3.39332636 |
| 33 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.34848512 |
| 34 | Villous atrophy (HP:0011473) | 3.34848512 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.32563829 |
| 36 | Hyperactive renin-angiotensin system (HP:0000841) | 3.24684541 |
| 37 | Restrictive lung disease (HP:0002091) | 3.23318595 |
| 38 | Recurrent abscess formation (HP:0002722) | 3.21588772 |
| 39 | Onycholysis (HP:0001806) | 3.19626930 |
| 40 | IgG deficiency (HP:0004315) | 3.07959424 |
| 41 | Abnormality of T cell physiology (HP:0011840) | 3.05275319 |
| 42 | Thyroiditis (HP:0100646) | 2.99734143 |
| 43 | Panhypogammaglobulinemia (HP:0003139) | 2.98779434 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.97989900 |
| 45 | Abnormality of the prostate (HP:0008775) | 2.96997515 |
| 46 | Abnormality of complement system (HP:0005339) | 2.88780716 |
| 47 | Dry hair (HP:0011359) | 2.85017225 |
| 48 | Recurrent bacterial skin infections (HP:0005406) | 2.84724033 |
| 49 | Basal cell carcinoma (HP:0002671) | 2.81025469 |
| 50 | Erythema (HP:0010783) | 2.80527645 |
| 51 | Decreased circulating renin level (HP:0003351) | 2.78934353 |
| 52 | Nasal polyposis (HP:0100582) | 2.76474455 |
| 53 | Autoimmune hemolytic anemia (HP:0001890) | 2.71217349 |
| 54 | Recurrent fungal infections (HP:0002841) | 2.64491298 |
| 55 | Myositis (HP:0100614) | 2.61970560 |
| 56 | Complement deficiency (HP:0004431) | 2.60528620 |
| 57 | Abnormality of glycolipid metabolism (HP:0010969) | 2.58923334 |
| 58 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.58923334 |
| 59 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.58923334 |
| 60 | Leukopenia (HP:0001882) | 2.56121633 |
| 61 | Ankyloglossia (HP:0010296) | 2.55720218 |
| 62 | Alopecia of scalp (HP:0002293) | 2.55132411 |
| 63 | Abnormality of T cells (HP:0002843) | 2.54643429 |
| 64 | Glomerulonephritis (HP:0000099) | 2.49440766 |
| 65 | Mediastinal lymphadenopathy (HP:0100721) | 2.47504345 |
| 66 | Bronchiectasis (HP:0002110) | 2.47079380 |
| 67 | Small epiphyses (HP:0010585) | 2.46686956 |
| 68 | Plantar hyperkeratosis (HP:0007556) | 2.45998212 |
| 69 | Squamous cell carcinoma (HP:0002860) | 2.45517901 |
| 70 | Neutropenia (HP:0001875) | 2.44456986 |
| 71 | Thrombocytosis (HP:0001894) | 2.44335194 |
| 72 | Dysostosis multiplex (HP:0000943) | 2.44160528 |
| 73 | Urticaria (HP:0001025) | 2.43987968 |
| 74 | Palmoplantar hyperkeratosis (HP:0000972) | 2.42032836 |
| 75 | Eczematoid dermatitis (HP:0000976) | 2.40230206 |
| 76 | Recurrent skin infections (HP:0001581) | 2.35243522 |
| 77 | Mitral stenosis (HP:0001718) | 2.32130602 |
| 78 | Skin ulcer (HP:0200042) | 2.29125368 |
| 79 | Abnormality of the nasal mucosa (HP:0000433) | 2.29048954 |
| 80 | Oral leukoplakia (HP:0002745) | 2.28947148 |
| 81 | Conical tooth (HP:0000698) | 2.28112491 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 2.26593507 |
| 83 | Neonatal death (HP:0003811) | 2.20352188 |
| 84 | Palmar hyperkeratosis (HP:0010765) | 2.19284863 |
| 85 | Abnormal tarsal ossification (HP:0008369) | 2.18271998 |
| 86 | Pulmonary infiltrates (HP:0002113) | 2.16049353 |
| 87 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.15487419 |
| 88 | Gastrointestinal infarctions (HP:0005244) | 2.13092290 |
| 89 | Nephritis (HP:0000123) | 2.12673859 |
| 90 | Alkalosis (HP:0001948) | 2.11813181 |
| 91 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.11021485 |
| 92 | Lymphoma (HP:0002665) | 2.10693991 |
| 93 | Vertebral compression fractures (HP:0002953) | 2.10689515 |
| 94 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.09502747 |
| 95 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.08351131 |
| 96 | Recurrent cutaneous fungal infections (HP:0011370) | 2.08351131 |
| 97 | Abnormality of oral frenula (HP:0000190) | 2.07664611 |
| 98 | Abnormality of incisor morphology (HP:0011063) | 2.05220147 |
| 99 | Increased IgM level (HP:0003496) | 2.03770298 |
| 100 | Abnormality of macrophages (HP:0004311) | 2.01851075 |
| 101 | Premature loss of primary teeth (HP:0006323) | 2.01648338 |
| 102 | Osteolytic defects of the hand bones (HP:0009699) | 2.01502576 |
| 103 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.01502576 |
| 104 | Agammaglobulinemia (HP:0004432) | 10.3525761 |
| 105 | Obstructive lung disease (HP:0006536) | 1.99970664 |
| 106 | Chronic obstructive pulmonary disease (HP:0006510) | 1.99970664 |
| 107 | Increased IgE level (HP:0003212) | 1.95642369 |
| 108 | Pustule (HP:0200039) | 1.95443273 |
| 109 | Ileus (HP:0002595) | 1.93877699 |
| 110 | Right ventricular cardiomyopathy (HP:0011663) | 1.93174256 |
| 111 | Thick nail (HP:0001805) | 1.92397880 |
| 112 | Ridged nail (HP:0001807) | 1.91515001 |
| 113 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.91375154 |
| 114 | Rhabdomyolysis (HP:0003201) | 1.91130880 |
| 115 | Viral hepatitis (HP:0006562) | 1.88373910 |
| 116 | Spontaneous hematomas (HP:0007420) | 1.87343747 |
| 117 | Arthralgia (HP:0002829) | 1.86203301 |
| 118 | Abnormality of T cell number (HP:0011839) | 1.85896533 |
| 119 | Myocardial infarction (HP:0001658) | 1.85763870 |
| 120 | Teleangiectasia of the skin (HP:0100585) | 1.84997114 |
| 121 | Annular pancreas (HP:0001734) | 1.84713699 |
| 122 | Encephalitis (HP:0002383) | 1.84038277 |
| 123 | Hypergammaglobulinemia (HP:0010702) | 1.83779151 |
| 124 | Dehydration (HP:0001944) | 1.83269562 |
| 125 | T lymphocytopenia (HP:0005403) | 1.80657449 |
| 126 | Autoimmune thrombocytopenia (HP:0001973) | 1.75554066 |
| 127 | Abnormality of the fingertips (HP:0001211) | 1.74301391 |
| 128 | Vacuolated lymphocytes (HP:0001922) | 1.71391201 |
| 129 | Flattened epiphyses (HP:0003071) | 1.66071083 |
| 130 | Microcytic anemia (HP:0001935) | 1.63874565 |
| 131 | External ear malformation (HP:0008572) | 1.61951231 |
| 132 | Stomatitis (HP:0010280) | 1.61124715 |
| 133 | Blepharitis (HP:0000498) | 1.61039318 |
| 134 | Fatigue (HP:0012378) | 1.60483634 |
| 135 | Chronic diarrhea (HP:0002028) | 1.58838872 |
| 136 | Petechiae (HP:0000967) | 1.54857126 |
| 137 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.51209773 |
| 138 | Retrobulbar optic neuritis (HP:0100654) | 1.48678064 |
| 139 | Optic neuritis (HP:0100653) | 1.48678064 |
| 140 | Irregular vertebral endplates (HP:0003301) | 1.38355218 |
| 141 | Acrocyanosis (HP:0001063) | 1.36670533 |
| 142 | Combined immunodeficiency (HP:0005387) | 1.34908939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 6.50087549 |
| 2 | MAP4K1 | 5.83585824 |
| 3 | PRPF4B | 4.85467359 |
| 4 | NME2 | 3.76864899 |
| 5 | SMG1 | 3.32093078 |
| 6 | CSF1R | 2.96531171 |
| 7 | GRK6 | 2.92228041 |
| 8 | MAP3K13 | 2.77605229 |
| 9 | SYK | 2.69350340 |
| 10 | TAF1 | 2.65988524 |
| 11 | TBK1 | 2.59544163 |
| 12 | MAP3K14 | 2.53797121 |
| 13 | TYK2 | 2.52880058 |
| 14 | RIPK4 | 2.47163784 |
| 15 | BLK | 2.36411796 |
| 16 | VRK2 | 2.32184934 |
| 17 | MAP3K10 | 2.26302519 |
| 18 | BTK | 2.11329273 |
| 19 | EIF2AK3 | 1.88035197 |
| 20 | IKBKE | 1.73814156 |
| 21 | IRAK3 | 1.69002359 |
| 22 | LYN | 1.67635838 |
| 23 | KIT | 1.67616175 |
| 24 | IRAK4 | 1.62657523 |
| 25 | MST1R | 1.57295514 |
| 26 | STK10 | 1.50503155 |
| 27 | SIK2 | 1.44327091 |
| 28 | MAP3K9 | 1.43997289 |
| 29 | TAOK3 | 1.43713329 |
| 30 | TAOK2 | 1.36687650 |
| 31 | IKBKB | 1.36205151 |
| 32 | JAK1 | 1.35586981 |
| 33 | LRRK2 | 1.34521453 |
| 34 | HCK | 1.33398123 |
| 35 | MAP3K1 | 1.26384757 |
| 36 | JAK3 | 1.24986145 |
| 37 | ARAF | 1.22112633 |
| 38 | MST4 | 1.15991996 |
| 39 | RIPK1 | 1.15631905 |
| 40 | TEC | 1.11792244 |
| 41 | EEF2K | 1.08665380 |
| 42 | ITK | 1.07189779 |
| 43 | BUB1 | 1.05167207 |
| 44 | STK24 | 1.01601998 |
| 45 | PRKCH | 0.97449832 |
| 46 | MAP2K3 | 0.96567440 |
| 47 | FES | 0.96161716 |
| 48 | NEK2 | 0.96079421 |
| 49 | IRAK1 | 0.95874041 |
| 50 | CSK | 0.95801420 |
| 51 | HIPK2 | 0.93881492 |
| 52 | LCK | 0.92775664 |
| 53 | PRKCQ | 0.92442506 |
| 54 | PIM1 | 0.91341537 |
| 55 | BRAF | 0.91053265 |
| 56 | MATK | 0.90271594 |
| 57 | KSR2 | 0.88241292 |
| 58 | GRK1 | 0.87638532 |
| 59 | SCYL2 | 0.87559808 |
| 60 | TGFBR2 | 0.86304401 |
| 61 | FRK | 0.82994896 |
| 62 | PDK2 | 0.82469190 |
| 63 | BCKDK | 0.79930543 |
| 64 | PDPK1 | 0.78454925 |
| 65 | NEK9 | 0.75779668 |
| 66 | NME1 | 0.74286611 |
| 67 | SIK3 | 0.73376898 |
| 68 | FGFR3 | 0.71598925 |
| 69 | CHUK | 0.70903529 |
| 70 | RPS6KA4 | 0.70790520 |
| 71 | ZAP70 | 0.69092763 |
| 72 | RAF1 | 0.68941628 |
| 73 | MAP3K2 | 0.68067543 |
| 74 | OXSR1 | 0.67323371 |
| 75 | SIK1 | 0.64927612 |
| 76 | NEK1 | 0.62493203 |
| 77 | MARK3 | 0.61498282 |
| 78 | MAP3K3 | 0.61233434 |
| 79 | MELK | 0.60714600 |
| 80 | CDK19 | 0.60499889 |
| 81 | PDK1 | 0.58086741 |
| 82 | BMPR2 | 0.54883484 |
| 83 | MAPKAPK5 | 0.51791807 |
| 84 | CLK1 | 0.51692658 |
| 85 | EPHB1 | 0.50145368 |
| 86 | PRKD2 | 0.49265935 |
| 87 | FGFR4 | 0.48929232 |
| 88 | ABL1 | 0.48928337 |
| 89 | MAPK7 | 0.47751568 |
| 90 | PIK3CG | 0.46103801 |
| 91 | MAP2K2 | 0.45854716 |
| 92 | ALK | 0.44575216 |
| 93 | TESK2 | 0.44485280 |
| 94 | FYN | 0.43235873 |
| 95 | CDK9 | 0.42544181 |
| 96 | MAP3K7 | 0.41402515 |
| 97 | PAK4 | 0.40796840 |
| 98 | MOS | 0.40260072 |
| 99 | IRAK2 | 0.40014919 |
| 100 | GRK5 | 0.39980540 |
| 101 | PKN2 | 0.39761436 |
| 102 | ACVR1B | 0.39686026 |
| 103 | PRKCD | 0.38967927 |
| 104 | PRKD1 | 0.38575551 |
| 105 | DAPK1 | 0.37727327 |
| 106 | MAPK12 | 0.37679367 |
| 107 | MAP3K8 | 0.37679112 |
| 108 | TXK | 0.37467791 |
| 109 | AKT2 | 0.37444402 |
| 110 | MAPKAPK3 | 0.36792841 |
| 111 | INSR | 0.36594823 |
| 112 | PRKCI | 0.36437283 |
| 113 | CDK12 | 0.34201557 |
| 114 | PRKG2 | 0.34186884 |
| 115 | FGR | 0.30885697 |
| 116 | PIK3CA | 0.30506183 |
| 117 | LMTK2 | 0.30391498 |
| 118 | MAPK11 | 0.30156850 |
| 119 | ICK | 0.29759999 |
| 120 | JAK2 | 0.28739814 |
| 121 | PKN1 | 0.28179295 |
| 122 | EIF2AK1 | 0.27014742 |
| 123 | TNK2 | 0.25208476 |
| 124 | EGFR | 0.24792671 |
| 125 | EIF2AK2 | 0.24301997 |
| 126 | CDK7 | 0.22967863 |
| 127 | MAPK4 | 0.22816992 |
| 128 | CDK4 | 0.21885504 |
| 129 | CCNB1 | 0.20570991 |
| 130 | CDC42BPA | 0.20294014 |
| 131 | MARK2 | 0.19917579 |
| 132 | CSNK1A1L | 0.19440104 |
| 133 | TRIB3 | 0.17891343 |
| 134 | CHEK2 | 0.16957221 |
| 135 | EPHA3 | 0.16392778 |
| 136 | KSR1 | 0.15946342 |
| 137 | MAPKAPK2 | 0.15438094 |
| 138 | BRD4 | 0.13668226 |
| 139 | MAPK3 | 0.13524678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 6.75644067 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.98240038 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 5.23172398 |
| 4 | Protein export_Homo sapiens_hsa03060 | 4.48325738 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.73562178 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.13257769 |
| 7 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.10507794 |
| 8 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.62949274 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.47763810 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.45254076 |
| 11 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.34032962 |
| 12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.09686375 |
| 13 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.87377339 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.84203159 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.81006914 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.78911449 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.68071277 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.60485558 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.59319666 |
| 20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.45130443 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.36761728 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.36560534 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.32229953 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30709293 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.29554690 |
| 26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.23815988 |
| 27 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.23292826 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.21614376 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.15584415 |
| 30 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.15579580 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.15563169 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.14589510 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.13757993 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.12647078 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.12419184 |
| 36 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.11906480 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.10368283 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.07428053 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05594397 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.04389191 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.03650340 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.00276273 |
| 43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.00060290 |
| 44 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.97469522 |
| 45 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.95851482 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.90577107 |
| 47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.89824578 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86410492 |
| 49 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.85008831 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.84962526 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.84762816 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.81987428 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80376321 |
| 54 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78117930 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77640954 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76639017 |
| 57 | Allograft rejection_Homo sapiens_hsa05330 | 0.76593437 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75536619 |
| 59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75414055 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74816059 |
| 61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.74111557 |
| 62 | DNA replication_Homo sapiens_hsa03030 | 0.73950885 |
| 63 | Pertussis_Homo sapiens_hsa05133 | 0.73175599 |
| 64 | Influenza A_Homo sapiens_hsa05164 | 0.72952816 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 0.72058910 |
| 66 | Legionellosis_Homo sapiens_hsa05134 | 0.71936217 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.68623339 |
| 68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67639181 |
| 69 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.66044747 |
| 70 | Shigellosis_Homo sapiens_hsa05131 | 0.64808013 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61018735 |
| 72 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60231497 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60194851 |
| 74 | Ribosome_Homo sapiens_hsa03010 | 0.60042242 |
| 75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59454098 |
| 76 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.59342002 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.59234733 |
| 78 | Bladder cancer_Homo sapiens_hsa05219 | 0.58590040 |
| 79 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.57267653 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55948884 |
| 81 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.53637789 |
| 82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53483914 |
| 83 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.51978756 |
| 84 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48836226 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48361755 |
| 86 | Long-term potentiation_Homo sapiens_hsa04720 | 0.47788904 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47433625 |
| 88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47075998 |
| 89 | Carbon metabolism_Homo sapiens_hsa01200 | 0.45148820 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44583953 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44561779 |
| 92 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43750812 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43748342 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | 0.43707610 |
| 95 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.42477204 |
| 96 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.41783017 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41336755 |
| 98 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37806910 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.37698392 |
| 100 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.37397230 |
| 101 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.35410331 |
| 102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35297962 |
| 103 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.34981440 |
| 104 | Mismatch repair_Homo sapiens_hsa03430 | 0.33024118 |
| 105 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.31477065 |
| 106 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.30637245 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30277533 |
| 108 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.29701241 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27942498 |
| 110 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.26910744 |
| 111 | Prostate cancer_Homo sapiens_hsa05215 | 0.26748345 |
| 112 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.25587036 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25049161 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.23737019 |
| 115 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.23489615 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22816550 |
| 117 | Proteasome_Homo sapiens_hsa03050 | 0.22703886 |
| 118 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.22502775 |
| 119 | Thyroid cancer_Homo sapiens_hsa05216 | 0.22234062 |
| 120 | Glioma_Homo sapiens_hsa05214 | 0.22058585 |
| 121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.21505889 |
| 122 | Lysosome_Homo sapiens_hsa04142 | 0.21355327 |
| 123 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.20829469 |
| 124 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.20782323 |
| 125 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20171847 |
| 126 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.19998722 |
| 127 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.19603331 |
| 128 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.19286088 |
| 129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.18984372 |
| 130 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.18452722 |
| 131 | Homologous recombination_Homo sapiens_hsa03440 | 0.18069214 |
| 132 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.14293580 |
| 133 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.13095313 |
| 134 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.10642675 |
| 135 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.10161564 |
| 136 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.08449514 |
| 137 | Histidine metabolism_Homo sapiens_hsa00340 | 0.07632845 |

